Machine learning-based discrimination of metabolic dysfunction-associated steatotic liver disease: implications of tryptophan metabolites as potential biomarkers.
OBJECTIVES Early screening of individuals at high risk of metabolic dysfunction-associated steatotic liver disease (MASLD) facilitates timely intervention and may reduce the risk of progression to cirrhosis. This study aimed to develop a reliable and clinically practical model for MASLD discrimination. METHODS A tota...